Clinical Trial Update: PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PD-1 inhibitor with anti-EGFR therapy and radiotherapy for locally advanced nasopharyngeal carcinoma resistant to induction ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN